Evaluation of Brain Damage Due to Coronary Angioplasty in Percutaneous Intervention Patients

Ondokuz Mayıs University

Status: Completed

Conditions: Coronary Disease; Silent Stroke

Treatments: Diagnostic Test: Blood serum Neuron-specific Enolase measurement

Study type: Observational

Funder types: Other

Identifiers

NCT04734587

SBI IN CTO INTERVENTION

Details and patient eligibility

About

This study examines the formation mechanism and patient-related factors of silent cerebral infarcts, whose importance has become increasingly recognized in patients undergoing percutaneous coronary intervention.

Full description

This study was produced from the assistant's thesis and was previously accepted as a poster at EuroPCR 2020. We recently completed the full-length article.

This thesis study was supported by Ondokuzmayis University.

Enrollment: 120 patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• CTO and Non-CTO patients undergoing percutaneous coronary intervention

Exclusion criteria

• baseline NSE elevation
• acute coronary syndromes or cardiac surgery within 4 weeks
• patients with a cerebrovascular accident
• intracranial hemorrhage
• and head trauma
• central nervous system tumor
• degenerative central nervous system disorders and neuroendocrine tumors

Trial design

120 participants in 2 patient groups

Chronic Total Occlusion

Description:

Chronic total occlusion patients undergoing percutaneous coronary intervention.

Treatment:

Diagnostic Test: Blood serum Neuron-specific Enolase measurement

Non-Chronic Total Occlusion

Description:

Non-Chronic total occlusion patients undergoing percutaneous coronary intervention.

Treatment:

Diagnostic Test: Blood serum Neuron-specific Enolase measurement